(PRWEB) June 21, 2013
Zamansky & Associates LLC announces that on behalf of shareholders it is investigating Ebix, Inc. (“Ebix”) over the termination of the planned merger with a Goldman Sachs affiliate. The investigation concerns the alleged conduct of Ebix’s senior officers and directors.
On June 20, 2013, BloombergNews reported that Goldman Sachs terminated its agreement to acquire Ebix in a merger valued at $20 per share. Goldman Sachs refused to forward with the transaction because the U.S. Attorney in Atlanta has opened a probe into allegations of intentional misconduct, BloombergNews reported. As a result of this news, BloombergNews reported, Ebix’s stock price fell 40%.
According to stock fraud attorney Jake Zamansky, Ebix’s failed merger agreement with Goldman Sachs has hurt shareholders. The investigation concerns alleged misconduct by Ebix’s senior officers and directors which caused Goldman Sachs to withdraw from the transaction. Long-term shareholders of Ebix should be upset by these events, according to Zamansky.
What Ebix Investors Can Do
If you would were an investor in Ebix stock and wish to discuss your legal rights, you may, without obligation or cost to you, email jake(at)zamansky(dot)com or call the law firm at (212) 742-1414.
If you have information that would assist with the investigation, please also contact us.
About Zamansky & Associates LLC
Zamansky & Associates LLC is one of the leading securities fraud law firms specializing in securities class actions and securities arbitration. We are stock fraud attorneys who represent both individual and institutional investors. Our practice is nationally recognized for our ability to aggressively prosecute cases and recover losses.
To learn more about Zamansky, please visit our website, http://www.zamansky.com.
Zamansky & Associates, LLC
50 Broadway - 32nd Floor
New York, NY 10004
Jake Zamansky, 212-742-1414